cytarabine has been researched along with Abnormalities, Multiple in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demir Yenigürbüz, F; Gözmen, S; İrken, G; Karapınar, TH; Ören, H; Tüfekçi, Ö | 1 |
Go, RS; Johnston, KL | 1 |
Distel, L; Grabenbauer, G; Holter, W; Neubauer, S; Varon, R | 1 |
Jones, KL; Kahole, NC; Vaux, KK | 1 |
Baehner, RL; Hill, JS; Wagner, VM; Weaver, D | 1 |
Lehmann, AR; Parshad, R; Price, FM; Sanford, KK; Tarone, RE | 1 |
Balcar-Boroń, A; Graduszewska-Czerebiej, K; Nowaczyk-Michalak, A | 1 |
Ritter, EJ; Scott, WJ; Wilson, JG | 1 |
1 review(s) available for cytarabine and Abnormalities, Multiple
Article | Year |
---|---|
Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia | 2003 |
7 other study(ies) available for cytarabine and Abnormalities, Multiple
Article | Year |
---|---|
Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
Topics: Abnormalities, Multiple; Allografts; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmunity; Cytarabine; Exons; Female; Genes, ras; Genetic Heterogeneity; Germ-Line Mutation; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myelomonocytic, Juvenile; Male; Mercaptopurine; Mutation, Missense; Point Mutation; Prednisolone; Proto-Oncogene Proteins c-cbl; Remission Induction | 2015 |
Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Cycle Proteins; Child; Chromosome Breakage; Cisplatin; Cytarabine; Death, Sudden, Cardiac; Etoposide; Fatal Outcome; Humans; Ifosfamide; Infratentorial Neoplasms; Male; Medulloblastoma; Methotrexate; Nuclear Proteins; Polymerase Chain Reaction; Syndrome | 2003 |
Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Apoptosis; Cyclophosphamide; Cytarabine; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Trimester, First | 2003 |
Congenital abnormalities in baby born to cytarabine treated mother.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Cytarabine; Female; Humans; Infant, Newborn; Leukemia, Lymphoid; Male; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Hematologic | 1980 |
G2 phase repair of X-ray-induced chromosomal DNA damage in trichothiodystrophy cells.
Topics: Abnormalities, Multiple; Ataxia Telangiectasia; Cell Line; Chromosome Aberrations; Chromosomes, Human; Cockayne Syndrome; Cytarabine; DNA Damage; DNA Repair; Down Syndrome; G2 Phase; Hair; Humans; Skin; Skin Diseases; X-Rays; Xeroderma Pigmentosum | 1995 |
[Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Humans; Infant; Leukemia, Myeloid, Acute; Male; Remission Induction; Tetralogy of Fallot; Thioguanine | 1992 |
Relationship of temporal patterns of cell death and development to malformations in the rat limb. Possible mechanisms of teratogenesis with inhibitors of DNA synthesis.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Cell Survival; Cytarabine; DNA; Ectoderm; Embryo Loss; Embryo, Mammalian; Embryonic and Fetal Development; Female; Fetal Death; Fetus; Forelimb; Hindlimb; Hydroxyurea; Limb Deformities, Congenital; Mesoderm; Necrosis; Palmitates; Pregnancy; Rats; Teratogens; Time Factors | 1973 |